BrightSpring Health Services, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

BrightSpring Health Services, Inc. (NASDAQ: BTSG), a leading provider of community-based and home health services in the United States, released its detailed financial results for the fourth quarter ended December 31, 2025, along with full year performance and guidance for 2026. The results were publicly announced before the market opened on February 27, 2026, providing investors with key insights into the company’s recent performance and future outlook.

Quarterly Financial Highlights: Revenue, Profit and Earnings Per Share

For the fourth quarter of 2025, BrightSpring reported total net revenue of $3.55 billion, representing a year-over-year increase of approximately 29.3% compared to the same quarter in 2024 when the company reported $2.75 billion. Revenue growth was driven by strong performance in its pharmacy solutions and provider services segments.

Despite solid revenue, the reported adjusted earnings per share (EPS) of $0.33 missed some analyst estimates, which were projected closer to $0.35-$0.36 by certain market trackers. This resulted in the company technically falling short of consensus estimates for EPS, although several operational metrics remained well-above expectations.

Gross profit for the quarter also grew significantly, with total gross earnings rising to approximately $413 million, reflecting an increase of more than 20% from the same period last year.

Segment Contributions and Operational Factors

The company’s Pharmacy Solutions segment continued to be a major contributor to overall revenue, showing strong prescription volume, improved average revenue per script, and robust margins. Meanwhile, the Provider Services business, which includes home health, hospice, personal care, and rehab services, also reported growth, supported by rising patient census and demographic demand.

Full Year 2025 Performance

BrightSpring’s full year results reflect sustained growth across revenue and profitability metrics for 2025. Total net revenue for the full year came in at approximately $12.91 billion, up nearly 28% from $10.07 billion in 2024. The company also reported a full-year net income of around $104.8 million, a notable turnaround from a net loss in the previous year.

Other key full-year highlights included:

• Adjusted EBITDA of $618 million, up over 34% from the prior year.
• Operating cash flow soared to approximately $490 million compared to just $24 million in 2024, indicating improved operational efficiency.
• Leverage metrics improved significantly, with leverage ratios declining from previous levels.

These results marked a strong overall performance for BrightSpring, driven by ongoing customer demand and operational improvements across business units.

Management Comments and Strategic Focus

In the press release, Jon Rousseau, Chairman, President, and CEO of BrightSpring Health Services, emphasized the company’s mission to provide high-quality, coordinated care across diverse populations. Rousseau highlighted progress in expanding service reach, scaling operations, and strengthening financial performance through disciplined cost management and strategic acquisitions.

Management also highlighted the importance of integrating acquired home health and hospice branches from previous acquisitions, which contributed meaningfully to revenue growth and expanded service capacity.

Guidance for 2026: Revenue and Adjusted EBITDA Outlook

Looking ahead, BrightSpring issued guidance for full year 2026 with projected revenue and profitability targets that signal continued growth. The company expects total revenue to fall within a range of approximately $14.45 billion to $15.00 billion, reflecting double-digit year-over-year growth. Adjusted EBITDA is forecast in the range of $760 million to $790 million, a significant increase compared to 2025.

This forward guidance suggests that management is confident in future demand for its services, continued operational leverage, and market expansion opportunities. Key drivers of growth include deeper penetration into pharmacy markets, continued strength in provider services, and disciplined integration of acquired businesses.

Market Reaction and Analyst Commentary

Following the earnings release, market reactions varied as investors digested both the revenue beat and the EPS miss. Trading activity indicated modest stock movement, and analysts reflected mixed expectations regarding future performance. Some investors focused on the strong revenue growth and rising EBITDA, while others noted the earnings per share outcome as an area for future improvement.

In the lead-up to the official announcement, industry analysts had been anticipating earnings that reflected continued momentum across segments, based on prior quarter performance and broader healthcare trends. Analysts’ consensus figures had projected moderate revenue gains year-over-year and modest profitability improvements.

Key Takeaways for Investors

Overall, BrightSpring’s fourth quarter and full year results highlight a company in the midst of growth, balancing revenue expansion with strategic cost management. Investors may consider the following points:

• Strong revenue performance: BTSG outpaced many expectations on total revenue growth.
• Profitability trend: While adjusted EPS lagged estimates, other profitability measures improved.
• Future potential: 2026 guidance shows continued confidence in long-term growth.
• Segment diversification: Multiple business units contribute to resilience and scale.

Conclusion

In summary, BrightSpring Health Services, Inc. delivered a mixed but fundamentally strong fourth quarter performance with notable revenue gains and improved full-year metrics. While adjusted earnings per share fell slightly below some estimates, the company demonstrated robust underlying growth driven by its core operations and strategic initiatives. With positive guidance for 2026, BrightSpring appears positioned to continue scaling its services and improving financial stability. Investors and industry watchers will continue to monitor execution and market developments as the company moves forward.

#BrightSpringEarnings #BTSG #HealthcareFinance #Q42025Results #SlimScan #GrowthStocks #CANSLIM